Trexquant Investment’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-11,909
Closed -$108K 1599
2020
Q4
$108K Sell
11,909
-29,449
-71% -$228K 0.01% 963
2020
Q3
$252K Buy
+41,358
New +$316K 0.02% 1000
2020
Q2
Sell
-50,587
Closed -$367K 1580
2020
Q1
$367K Buy
+50,587
New +$375K 0.03% 775
2019
Q2
Sell
-14,601
Closed -$92K 1234
2019
Q1
$92K Sell
14,601
-39,681
-73% -$278K 0.01% 935
2018
Q4
$352K Buy
54,282
+28,377
+110% +$217K 0.02% 738
2018
Q3
$215K Buy
+25,905
New +$197K 0.02% 804
2016
Q4
Sell
-22,800
Closed -$373K 1193
2016
Q3
$373K Buy
+22,800
New +$321K 0.08% 394
2015
Q3
Sell
-54,080
Closed -$493K 1334
2015
Q2
$493K Buy
+54,080
New +$410K 0.06% 628

Other funds holding NPTN

Trexquant Investment's NPTN Position: Q1 2021 in Review

Trexquant Investment sold out of NEOPHOTONICS CORP (NPTN) in Q1 2021, closing a stake of 11,909 shares — an estimated $108K sold.

Trexquant Investment first reported a position in NPTN in Q2 2015 and held it in 8 quarters. The position peaked at $493K in Q2 2015. 147 funds tracked by Wall St. Rank hold NPTN as of Q1 2021.

  • Trexquant Investment reported no remaining NEOPHOTONICS CORP position as of Q1 2021 after selling out during the quarter.
  • Trexquant Investment sold 11,909 NEOPHOTONICS CORP shares in Q1 2021, an estimated $108K.
  • Trexquant Investment first reported a position in NEOPHOTONICS CORP in Q2 2015 and held it in 8 quarters.
  • Trexquant Investment's NEOPHOTONICS CORP position peaked at $493K in Q2 2015.
  • 147 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2021.

Based on Trexquant Investment's 13F filing for Q1 2021, filed 13 May 2021.